Fabrication of drug nanoparticles by evaporative precipitation of nanosuspension

International Journal of Pharmaceutics

Volumn 383, Issue 1-2, 2010, Pages 285-292

  Kakran, M ^a   Sahoo, N G ^a   Li, L ^a   Judeh, Z ^b   Wang, Y ^c   Chong, K ^d   Loh, L ^d  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b Nanyang Technological University   (Singapore)

^c INNER MONGOLIA MEDICAL COLLEGE   (China)

^d SCHOOL OF ENGINEERING   (Singapore)

Author keywords

Artemisinin; Crystallinity; Dissolution; Malaria; Nanoparticles

Indexed keywords

ARTEMISIN;

ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG SOLUBILITY; NANOFABRICATION; NANOPHARMACEUTICS; PARTICLE SIZE; POWDER; PRECIPITATION; PRIORITY JOURNAL; RESPONSE SURFACE METHOD; SCANNING ELECTRON MICROSCOPY; SUSPENSION; X RAY DIFFRACTION;

ANTIMALARIALS; ARTEMISININS; CHEMICAL PRECIPITATION; CHEMISTRY, PHARMACEUTICAL; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; PARTICLE SIZE; POWDERS; SOLUBILITY; SUSPENSIONS;

EID: 70449536481     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.09.030     Document Type: Article

References (28)

1. Amidon G.L., Lennernas H., Shah V.P., and Crison J.R. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12 (1995) 413-420
2. Augustijns P., D'Hulst A., Daele J.V., and Kinget R. Transport of artemisinin and sodium arsenate in caco-2 intestinal epithelial cells. J. Pharm. Sci. 85 (1996) 577-579
3. Barradell L.B., and Fitton A. Artesunate. A review of its pharmacology and therapeutic efficacy in the treatment of malaria. Drugs 50 (1995) 714-741
4. Billon A., Bataille B., Cassanas G., and Jacob M. Development of spray-dried acetaminophen microparticles using experimental designs. Int. J. Pharm. 203 (2000) 159-168
5. Dollo G., Le Corre P., Guerin A., Chevanne F., Burgot J.L., and Leverge R. Spray-dried redispersible oil-in-water emulsion to improve oral bioavailability of poorly soluble drugs. Eur. J. Pharm. Biopharm. 19 (2004) 273-280
6. Grau M.J., Kayser O., and Muller R.H. Nanosuspensions of poorly soluble drugs-reproducibility of small scale production. Int. J. Pharm. 196 (2000) 155-157
7. Guozhong C. Nanostructures & Nanomaterials: Synthesis Properties & Applications (2003), Imperial College Press, London pp. 53-62
8. Hancock B.C., and Zografi G. Characteristics and significance of the amorphous state in pharmaceutical systems. J. Pharm. Sci. 86 (1997) 1-12
9. Hu J., Rogers T.L., Brown J.N., Young T.J., Johnston K.P., and Williams R.O. Improvement of dissolution rates of poorly water soluble APIs using the novel spray freezing into liquid technology. Pharm. Res. 19 (2002) 1278-1284
10. Jung J., and Perrut M. Particle design using supercritical fluids: literature and patent survey. J. Super Fluids 20 (2001) 179-219
11. Lipinski C. Poor aqueous solubility-an industry wide problem in drug delivery. Am. Pharm. Rev. 5 (2002) 82-85
12. Lipinski C.A., Lombardo F., Dominy B.W., and Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46 (2001) 3-26
13. Merisko-Liverside E., Liversidge G.G., and Cooper E.R. Nonosizing: a formulation approach for poorly-water soluble compounds. Eur. J. Pharm. Sci. 18 (2003) 113-120
14. Merisko-Liversidge E. Nanocrystals: Resolving Pharmaceutical Formulation Issues Associated with Poorly Water-soluble Compounds in Particles (2002), Marcel Dekker, Orlando
15. Michal E., Matteucci, Margaret A., Hotze, Keith P., Johnston, Robert O., and Williams. Drug nanoparticles by antisolvent precipitation: mixing energy versus surfactant stabilization. Langmuir 22 (2006) 8951-8959
16. Moretti M.D.L., Gavini E., Juliano C., Pirisino G., and Giunchedi P. Spray-dried microspheres coantaining ketoprofen formulated into capsules and tablets. J. Microencapsul. 18 (2001) 111-121
17. Muhrer G., Meier U., Fusaro F., Albano S., and Mazzotti M. Use of compressed gas precipitation to enhance the dissolution behavior of a poorly water soluble drug: generation of drug microparticles and drug-polymer dispersions. Int. J. Pharm. 308 (2006) 69-83
18. Noyes A.A., and Whitney W.R. The rate of solution of solid substances in their own solutions. J. Am. Chem. Soc. 19 (1897) 930-934
19. Rasenack N., Hartenhauer H., and Muller B.W. Microcrystals for dissolution rate enhancement of poorly water-soluble drugs. Int. J. Pharm. 254 (2003) 137-145
20. Rogers T.L., Hu J., Yu Z., Johnston K.P., and Williams R.O. A novel particle engineering technology: spray-freezing into liquid. Int. J. Pharm. 242 (2002) 93-100
21. Rogers T.L., Overhoff K.A., Shah P., Santiago P., Yacaman M.J., Johnson K.P., and William III R.O. Micronized powders of a poorly water soluble drug produced by a spray-feezing into liquid-emulsion process. Eur. J. Pharm. Biopharm. 55 (2003) 161-172
22. Shariati A., and Peters C.J. Recent developments in particle design using supercritical fluids. Curr. Opin. Solid State Mater. Sci. 7 (2003) 371-383
23. Subramaniam B., Rajewski R.A., and Snavely K. Pharmaceutical processing with supercritical carbon dioxide. J. Pharm. Sci. 86 (1997) 885-890
24. Titulaer H.A.C., Zuidema J., and Lugt C.B. Formulation and pharmacokinetics of arthemisinin and its derivatives. Int. J. Pharm. 69 (1991) 83-92
25. Wong J.W., and Yuen K.H. Improved oral bioavailability of artemisinin through inclusion complexation with β-, and γ- cyclodextrins. Int. J. Pharm. 227 (2001) 177-185
26. Wong J.W., and Yuen K.H. Inclusion complexation of artemisinin with α-,β-, and γ- cyclodextrins. Drug Dev. Ind. Pharm. 29 (2003) 1035-1044
27. In: Yalkowsky S.H. (Ed). Techniques of Solubilization of Drugs (1981), Marcel Dekker, NY
28. Zhao S.S. High-performance liquid chromatographic determination of artemisinin (qinghaosu) in human plasma and saliva. Analyst 112 (1987) 661-664